A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol

Mastall, MaximilianRoth, PatrickBink, AndreaFischer Maranta, AngelaLäubli, HeinzHottinger, Andreas FelixHundsberger, ThomasMigliorini, DenisOchsenbein, AdrianSeystahl, KatharinaImbach, LukasHortobágyi, TiborHeld, LeonhardWeller, MichaelWirsching, Hans-Georg2025-04-072025-04-072024Bmc Cancer. -24 : 1 (2024), p. 1-7. -(cikkazonosító)82. -BMC Cancer. - 1471-2407. - 1471-24071471-2407https://hdl.handle.net/2437/388925A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocolfolyóiratcikkopen access journalhttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM129344OrvostudományokKlinikai orvostudományokhttps://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11797-zszerzőhttp://dx.doi.org/10.1186/s12885-023-11797-z2025-04-0700114387390000685182461604